Objective: To investigate minimally invasive administration of contrast agent to the middle ear and the enhancement efficacy on the inner ear compartments. Materials and Methods: An ultra-small volume of gadolinium-tetraazacyclododecane tetraacetic acid (Gd-DOTA) was injected onto the medial wall of the rat middle ear with a high-performance polyimide tube. The dynamic Gd-DOTA distribution in the inner ear was visualized in vivo by MRI. Results: After injection of 2.5 µl of 0.5M Gd-DOTA, uptake first occurred in the vestibulum, then in the scala vestibuli, and finally in the scala tympani (ST). A significant difference in signal intensities among these compartments was demonstrated with an intensity gradient, indicating that the vestibulum was the highest and the ST was the lowest. After 24 h, Gd-DOTA remained in the inner ear and the vestibule remained higher compared to the cochlea. The signal/noise ratio was significantly improved by a fluid-attenuated inversion recovery sequence. Conclusions: This novel minimally invasive technique can be applied to both animal studies and clinical evaluations of inner ear barrier function and fluid spaces with gadolinium-enhanced MRI. This technique might also be exploited for use as a minimally invasive drug delivery means for inner ear treatment.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.